BiomX PHGE
NYSE PHGE
$0.14 0.00 (-1.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

BiomX (PHGE) Accumulated Expenses (2021 - 2025)

BiomX (PHGE) posted Accumulated Expenses of $720000.0 for Q4 2025, down 5.51% sequentially from $762000.0 in Q1 2025, and down 15.69% YoY from $854000.0 in Q4 2024.

BiomX (PHGE) Accumulated Expenses (2021 - 2025) Analysis & Trends

BiomX has reported Accumulated Expenses for 5 years, with the latest figure at $720000.0 in Q4 2025.

  • Quarterly Accumulated Expenses fell 15.69% year-over-year to $720000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $720000.0 (down 15.69% YoY) and the FY2025 annual result came in at $720000.0, down 15.69% from the prior year.
  • Accumulated Expenses eased to $720000.0 in Q4 2025 per PHGE's latest filing, from $762000.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $5.5 million in Q4 2021 and troughed at $720000.0 in Q4 2025.
  • A 5-year average of $2.3 million and a median of $1.7 million in 2022 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Expenses slumped 83.73% in 2022, then soared 45.32% in 2023.
  • Over 5 years, Accumulated Expenses stood at $5.5 million in 2021, then plunged by 83.73% to $887000.0 in 2022, then soared by 45.32% to $1.3 million in 2023, then sank by 33.75% to $854000.0 in 2024, then declined by 15.69% to $720000.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $720000.0, $762000.0, and $854000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 BiomX 351,774.34 -816,225.66 -

Historic Data

Download Data
DateValue
Dec 31, 2025 720,000.00
Mar 31, 2025 762,000.00
Dec 31, 2024 854,000.00
Sep 30, 2024 3.42 Mn
Jun 30, 2024 1.23 Mn
Dec 31, 2023 1.29 Mn
Mar 31, 2023 2.96 Mn
Dec 31, 2022 887,000.00
Sep 30, 2022 2.02 Mn
Jun 30, 2022 2.39 Mn
Mar 31, 2022 5.25 Mn
Dec 31, 2021 5.45 Mn